This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SGO | Ann: Half Yearly Report and Accounts | 14:52 | 0 | 100 | |||
|
|||||||
SGO | Ann: Appendix 4C - quarterly | 31/01/19 | 0 | 148 | |||
|
|||||||
SGO | Ann: Ceasing to be a substantial holder | 12/12/18 | 0 | 106 | |||
|
|||||||
SGO | Ann: Ceasing to be a substantial holder | 12/12/18 | 0 | 96 | |||
|
|||||||
SGO | Ann: Results of Meeting | 12/11/18 | 0 | 106 | |||
|
|||||||
SGO | Ann: Appendix 4C - quarterly | 31/10/18 | 0 | 125 | |||
|
|||||||
SGO | Ann: AGM Proxy Form | 11/10/18 | 0 | 99 | |||
|
|||||||
SGO | Ann: Notice of Annual General Meeting | 11/10/18 | 0 | 122 | |||
|
See All Discussions